Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SLV-154
- Development stage
- Phase 1
- Lead developer
- Solve Therapeutics
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
SLV-154 is an investigational intravenous antineoplastic agent developed by Solve Therapeutics for the treatment of metastatic solid tumors and a range of advanced cancers. It is currently in early clinical development, with a Phase 1 dose-escalation study underway to evaluate its safety, pharmacokinetics, pharmacodynamics, immunogenicity, and preliminary efficacy in patients with metastatic solid tumors. The precise mechanism of action for SLV-154 has not been disclosed as of the latest updates. Indications under investigation include advanced breast cancer (including HER2 positive), cervical cancer, endometrial cancer, head and neck cancer, non-small cell lung cancer, ovarian cancer, sarcoma, small cell lung cancer, squamous cell carcinoma, urogenital cancers as well as other solid tumors.
- Other names
- SLV 154SLV154SLV-154
Beyond the preview
Go deeper on SLV-154.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SLV-154.